# Fountain of Youth

> Combination — not ranked · Combos · reviewed 2026-11-08
> Source page: https://peptidemeta.com/p/fountain-of-youth/

Also known as: FOY blend

## Quick answers

**What is Fountain of Youth?**

An anti-aging blend typically combining Epithalon, GHK-Cu, and a growth hormone secretagogue to address telomere length, skin quality, and overall vitality simultaneously. Epitalon plus GHK-Cu plus an unnamed growth-hormone secretagogue (per catalog). Exact contents vary by seller.

**What is in Fountain of Youth?**

Fountain of Youth typically combines Epithalon and GHK-Cu. Commercial products vary.

**How strong is the evidence for Fountain of Youth?**

It is not ranked. A PubMed search found no published studies of this combination; only reviews mention it. Epitalon has only small human studies; GHK-Cu is mostly lab and skin research; the GH secretagogue is not specified.

**Is Fountain of Youth FDA-approved?**

No. Fountain of Youth is not an approved product; no regulator has reviewed the combination.

**Is Fountain of Youth banned in sport?**

Yes. Fountain of Youth is prohibited in sport by the World Anti-Doping Agency under S0, S2.

**How does Fountain of Youth work?**

The Fountain of Youth blend is promoted as targeting three aging pathways: Epithalon, which induced telomerase in cultured human cells, GHK-Cu, which is studied for extracellular matrix remodeling and collagen synthesis, and a GH secretagogue intended to raise growth hormone. None of these combined effects has been tested in humans.

**What is known about the safety of Fountain of Youth?**

Individual components have documented safety profiles. Epithalon has theoretical telomerase/cancer concerns.

## Key facts

- **Evidence tier:** not ranked
- **FDA:** not approved
- **WADA:** prohibited (S0, S2)
- **Peptide:** yes
- **Routes studied:** Subcutaneous, Intramuscular
- **Components:** Epithalon, GHK-Cu

## Overview

An anti-aging blend typically combining Epithalon, GHK-Cu, and a growth hormone secretagogue to address telomere length, skin quality, and overall vitality simultaneously.

## Mechanism

The Fountain of Youth blend is promoted as targeting three aging pathways: Epithalon, which induced telomerase in cultured human cells, GHK-Cu, which is studied for extracellular matrix remodeling and collagen synthesis, and a GH secretagogue intended to raise growth hormone. None of these combined effects has been tested in humans.

## Effects reported in research

_Reported outcomes, not promises; see the evidence tier._

- Multi-pathway anti-aging support
- Telomere and skin rejuvenation
- Improved GH-mediated recovery
- Enhanced overall vitality markers

## Safety & unknowns

Individual components have documented safety profiles. Epithalon has theoretical telomerase/cancer concerns. GHK-Cu is well-tolerated. GH secretagogues carry standard GH-related risks. No combination-specific safety data. Proprietary formulations vary by provider. Not FDA-approved as a combination.

## Studies

- Khavinson VKh, Bondarev IE, Butyugov AA, et al. (2004). *Peptide promotes overcoming of the division limit in human somatic cell*. Bulletin of Experimental Biology and Medicine. Preclinical. https://pubmed.ncbi.nlm.nih.gov/15455129/
  Cell-culture study on the Epithalon component: treated human fetal fibroblasts showed telomere elongation and extra cell divisions.
- Pickart L, Vasquez-Soltero JM, Margolina A. (2015). *GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration*. BioMed Research International. Review. https://pubmed.ncbi.nlm.nih.gov/26236730/
  Review of the GHK-Cu component, covering its proposed roles in wound healing, collagen synthesis, and skin repair.

## Status sources

- [Epitalon and Epithalamin: narrative review (Int J Mol Sci 2026)](https://pubmed.ncbi.nlm.nih.gov/42884164/)
- [Pickart et al. 2015 — GHK and skin regeneration (review)](https://pubmed.ncbi.nlm.nih.gov/26236730/)
- [WADA 2026 Prohibited List — S0 (epitalon); S2.2.4 growth hormone secretagogues](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf)

---

Educational reference only — not medical advice. No dosing information is published. Tiers rate the strength of published evidence, not effectiveness or safety.